Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amer Sports Inc (AS) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Amer Sports IncTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Amer Sports Inc vs IDEXX Laboratories, Inc. — how do they compare? Amer Sports Inc trades at $33.48 (market cap $19.69B), while IDEXX Laboratories, Inc. trades at $573.46 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.3× Amer Sports Inc's market cap, and Amer Sports Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.

ASIDXX
Market Cap
$19.69B$46.22B
Sector
TechnologyHealth
52-Week High
$41.96$766.68
52-Week Low
$29.54$526.44
Enterprise Value
$20.01B$47.12B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amer Sports Inc

Amer Sports (AS) trades at $33.47, down 7.46% over 24 hours amid a bearish technical signal. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $0.38 surpassing expectations. Revenue growth remains strong at 32% year-over-year in Q1 2026, and the company raised its full-year guidance. Analyst consensus is overwhelmingly bullish with a $58.67 price target, though technical indicators suggest near-term weakness.

The outlook is positive given robust fundamentals and upward earnings revisions, but risks include execution on growth targets and market volatility. The current price presents a potential entry point relative to analyst targets, though investors should monitor the upcoming Q2 2026 earnings report on August 18, 2026, for confirmation of continued momentum.

IDEXX Laboratories, Inc.

IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.

The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amer Sports Inc

Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, and Atomic. It designs and manufactures high-quality equipment, apparel, and footwear for athletes worldwide.

Read more on AS

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX